Recent Blog Articles
How — and why — to fit more fiber and fermented food into your meals
Tick season is expanding: Protect yourself against Lyme disease
What? Another medical form to fill out?
How do trees and green spaces enhance our health?
A muscle-building obsession in boys: What to know and do
Harvard Health Ad Watch: New drug, old song, clever tagline
Concussion in children: What to know and do
What color is your tongue? What's healthy, what's not?
Your amazing parathyroid glands
When — and how — should you be screened for colon cancer?
Cancer Archive
Articles
Focal therapy for prostate cancer?
Two teams of researchers suggest that focal therapy may be a promising treatment option for men with cancer confined to the prostate. However, more research is needed to determine its long-term effectiveness.
Calcium and prostate cancer risk
Physicians and researchers have long believed that consuming high amounts of calcium and dairy products increases the risk of prostate cancer, although study results have been inconsistent. Two recent studies make clear that the jury is still out.
Obesity may affect PSA levels, delay cancer diagnosis
Obese men tend to have lower PSA concentrations than men with healthier weights. As a result, fewer obese men undergo biopsies, potentially leaving prostate cancer undetected.
Hormone therapy for prostate cancer puts heart at risk
A study by Boston researchers found that hormone therapy may increase risk of death from heart disease, especially among patients who have had prostate surgery.
Lycopene and tomatoes: No shield against prostate cancer
Studies reveal that lycopene, a nutrient found in tomatoes, does not seem to reduce prostate cancer risk.
How to tell when localized cancer is advancing
A British study finds that repeat biopsies may play an important role in active surveillance for untreated, localized prostate cancer.
Anxiety drives some treatment decisions
Anxiety, not clinical symptoms and disease progression, may sway patients toward treatment.
Biomarker predicts the development of hormone refractory disease
Blood and tissue levels of chromogranin A (CgA) may be early indication that prostate cancer that won’t respond for long to hormone therapy.
BPH drug cleared of causing aggressive tumors
Study finds that finasteride may actually lower the overall risk of prostate cancer and aid in the detection of aggressive tumors. An earlier study had implicated finasteride in the development of these deadlier tumors.
Recent Blog Articles
How — and why — to fit more fiber and fermented food into your meals
Tick season is expanding: Protect yourself against Lyme disease
What? Another medical form to fill out?
How do trees and green spaces enhance our health?
A muscle-building obsession in boys: What to know and do
Harvard Health Ad Watch: New drug, old song, clever tagline
Concussion in children: What to know and do
What color is your tongue? What's healthy, what's not?
Your amazing parathyroid glands
When — and how — should you be screened for colon cancer?
Free Healthbeat Signup
Get the latest in health news delivered to your inbox!
Sign Up